Form 4: Bio-Rad CFO Roop Kalyan Lakkaraju Reports Stock Transactions
SEC Form 4 Filing
Roop Kalyan Lakkaraju, CFO of Bio-Rad Laboratories, reports the vesting of restricted stock units and a disposition of shares to cover tax obligations.
Summary
- On April 24, 2025, Roop Kalyan Lakkaraju, the EVP and CFO of Bio-Rad Laboratories, reported transactions involving Bio-Rad Class A common stock.
- Lakkaraju acquired 1,077 shares upon the vesting of restricted stock units at a price of $0.
- He also disposed of 386 shares to satisfy tax withholding obligations at a price of $249.74 per share.
- Following these transactions, Lakkaraju directly owns 845.384 shares of Bio-Rad Class A common stock.
- The report also notes that Lakkaraju acquired 66.8810 shares under the Bio-Rad Employee Stock Purchase Plan on March 31, 2025.
- Lakkaraju also holds 3,234 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock. It is standard practice for executives to receive stock-based compensation and to sell shares to cover tax liabilities upon vesting.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- The vesting schedule of the restricted stock units (four equal annual installments) is a common arrangement.
- The sale of shares to cover tax obligations is a typical occurrence after the vesting of equity awards.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The filing provides transparency to shareholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Acquisition of 66.8810 shares under the Bio-Rad Employee Stock Purchase Plan. |
| 04/24/2025 | Vesting of 1,077 restricted stock units and disposition of 386 shares for tax obligations. |
| 04/24/2025 | Date of report. |
Keywords
Bio-Rad Laboratories, Roop Kalyan Lakkaraju, Form 4, Stock Transactions, Restricted Stock Units, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.